Funding announcement
Opal Therapeutics Inc and Massachusetts General Hospital enter Joint Development Collaboration and Initiate HIV Immunotherapy Clinical Studies - Therapeutic Vaccine Trials to Start in London, UK
Opal Therapeutics partners with Massachusetts General Hospital on an HIV immunotherapy collaboration as human trials begin in London; the biotech counts Alloy Ventures, Alta Partners and GBS Ventures among its backers.